Literature DB >> 1672061

Cross-national changes in the effects of peptic ulcer disease.

B S Bloom1.   

Abstract

OBJECTIVE: To describe and to analyze the changing effects of peptic ulcer disease over time.
DESIGN: Variables relating to peptic ulcer disease from 1970-1986 were compared. The variables included rates of mortality, hospitalizations, operations, physician visits, and endoscopies, and the amount of disability-related loss of work and early retirement in six countries (Belgium, England and Wales, the Federal Republic of Germany, The Netherlands, Sweden, and the United States). MEASUREMENTS: Nonparametric epidemiologic time-trend analysis. MAIN
RESULTS: The historic, slow, declining trend in mortality and hospitalization rates continued. The rate of operations for peptic ulcer disease exhibited a large, one-time reduction, then returned to a parallel declining trend, but at a lower level. The rate of physician visits declined by 50%. The greatest changes were found in the rate of endoscopy use and in disability-related loss of work and early retirement, where increasing trends were quickly followed by decreasing trends. The elderly, especially women, generally did not share many of these benefits.
CONCLUSIONS: The effects of new interventions can be understood more fully by examining several variables in many countries over a long time. Contrary to expectations, the effects of the widespread use of histamine H2 antagonists have been more indirect (affecting work loss and disability retirement more) than direct (affecting high-cost medical service use and mortality less).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672061     DOI: 10.7326/0003-4819-114-7-558

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy.

Authors:  B S Bloom
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

2.  Comparison of laparoscopic truncal vagotomy with gastrojejunostomy and open surgery in peptic pyloric stenosis.

Authors:  Seok-Mo Kim; Jyewon Song; Sung Jin Oh; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

Review 3.  Formulary management of antiulcer drugs: economic considerations.

Authors:  P P Tucker; D B Nash
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

4.  Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects.

Authors:  J Higham; J-Y Kang; A Majeed
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

5.  Decreasing trend of upper gastrointestinal bleeding mortality risk over three decades.

Authors:  Amir Taefi; Won Kyoo Cho; Mehdi Nouraie
Journal:  Dig Dis Sci       Date:  2013-07-05       Impact factor: 3.199

6.  Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease.

Authors:  Loes E Visser; Hayo H Graatsma; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

Review 7.  Prescribing policy for antiulcer treatment in the elderly.

Authors:  G Bianchi Porro; M Lazzaroni
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

8.  Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study.

Authors:  S J Rosenstock; T Jørgensen
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

9.  Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992.

Authors:  P Sipponen; T Helske; P Järvinen; H Hyvärinen; K Seppälä; M Siurala
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.